Company Filing History:
2 out of 29 
1 out of 6 
1 out of 10,754 
Years Active: 1981-2006
Title: Innovations of Henri Brunner
Introduction
Henri Brunner is a notable inventor based in Lappersdorf, Germany. He has made significant contributions to the field of chemistry, particularly in the development of novel compounds for medical applications. With a total of five patents to his name, Brunner's work focuses on innovative solutions for treating tumor diseases.
Latest Patents
Brunner's latest patents include groundbreaking inventions such as water-soluble porphyrin platinum compounds with high tumor selectivity. These compounds are designed for the treatment of both benign and malignant tumor diseases. Specifically, they are suitable for photodynamic anti-tumor therapy, showcasing their potential in cancer treatment. Another notable patent involves ethylene-substituted phenylalkylethylenediamine-platinum (II or IV) complexes, which exhibit antitumor properties. These complexes are characterized by a complex formula that allows for various substitutions, enhancing their effectiveness in medical applications.
Career Highlights
Throughout his career, Henri Brunner has worked with prominent companies in the pharmaceutical and chemical industries. He has been associated with Asta Pharma Aktiengesellschaft and Asta-Werke Aktiengesellschaft, Chemische Fabrik. His work in these organizations has contributed to the advancement of innovative medical treatments.
Collaborations
Brunner has collaborated with notable professionals in his field, including Jurgen Engel and Peter Hankofer. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his inventions.
Conclusion
Henri Brunner's contributions to the field of chemistry and medicine through his innovative patents demonstrate his commitment to advancing treatment options for tumor diseases. His work continues to inspire future research and development in this critical area.